Tumefactive multiple sclerosis lesions under fingolimod treatment

Neurology

Volumn 81, Issue 4, 2013, Pages 403-

  Kinney, Michael O ^a   McDonnell, Gavin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FINGOLIMOD; GLATIRAMER; METHYLPREDNISOLONE; OLIGOCLONAL BAND; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; PROPANEDIOL DERIVATIVE; SPHINGOSINE;

APRAXIA; ATAXIA; CEREBRAL PEDUNCLE; CEREBROSPINAL FLUID; COGNITIVE DEFECT; CONCENTRATION LOSS; DISEASE COURSE; DRUG WITHDRAWAL; HOMONYMOUS HEMIANOPIA; HUMAN; MULTIPLE SCLEROSIS; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; VISUAL DISORDER; BRAIN; FEMALE; MYELINATED NERVE; PATHOLOGY;

BRAIN; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; PROPYLENE GLYCOLS; SPHINGOSINE;

EID: 84881275456     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31829deeb4     Document Type: Note

References (4)

1. Visser F, Wattjes MP, Pouwels PJ, Linssen WH, van Oosten BW. Tumefactive multiple sclerosis lesions under fingolimod treatment. Neurology 2012;79:2000-2002.
2. Castrop F, Kowarik MC, Albrecht H, et al. Severe multiple sclerosis: relapse under fingolimod therapy: incident or coincidence. Neurology 2012;78:928-930.
3. Jander S, Turowski B, Kieseier BC, Hartung HP. Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod. Mult Scler 2012;18:1650-1652.
4. Centonze D, Rossi S, Rinaldi F, Gallo P. Severe relapses under fingolimod treatment prescribed after natalizumab. Neurology 2012;79:2004-2005.